Sergio Coffa

Array ( [id] => 9748497 [patent_doc_number] => 08839962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Separation and/or purification of B0 from C0' [patent_app_type] => utility [patent_app_number] => 13/389597 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2382 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530175 [patent_doc_number] => 08754048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Light-receiving channel rhodopsin having improved expression efficiency' [patent_app_type] => utility [patent_app_number] => 13/389755 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8013 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324391 [patent_doc_number] => 20120196807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'KIDNEY-TARGETING DRUG DELIVERY AGENT COMPRISING RECOMBINANT GELATIN' [patent_app_type] => utility [patent_app_number] => 13/387664 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10576 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992626 [patent_doc_number] => 20110014279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/845485 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26190 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014279.pdf [firstpage_image] =>[orig_patent_app_number] => 12845485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000352 [patent_doc_number] => 09044425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Method for topical treatment of eye disease and composition and device for said treatment' [patent_app_type] => utility [patent_app_number] => 12/838733 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5966 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12838733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253064 [patent_doc_number] => 20120157391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'PROTEOGLYCAN-CONTAINING MATERIAL' [patent_app_type] => utility [patent_app_number] => 13/383987 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15070 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157391.pdf [firstpage_image] =>[orig_patent_app_number] => 13383987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038234 [patent_doc_number] => 09078929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'ε-Polylysine conjugates and the use thereof' [patent_app_type] => utility [patent_app_number] => 13/384789 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14890 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173575 [patent_doc_number] => 20120108515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION' [patent_app_type] => utility [patent_app_number] => 13/379146 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10653 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108515.pdf [firstpage_image] =>[orig_patent_app_number] => 13379146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160123 [patent_doc_number] => 20120101040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => ' ANGIOGENESIS INDUCING AGENT COMPRISING RECOMBINANT GELATIN' [patent_app_type] => utility [patent_app_number] => 13/319289 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6435 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101040.pdf [firstpage_image] =>[orig_patent_app_number] => 13319289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391714 [patent_doc_number] => 20100303790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'USE OF BILIVERDIN REDUCTASE (BVR) AND BVR PEPTIDE FRAGMENTS TO TREAT CORONARY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/775218 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18788 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303790.pdf [firstpage_image] =>[orig_patent_app_number] => 12775218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046807 [patent_doc_number] => 08541361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Composition' [patent_app_type] => utility [patent_app_number] => 13/264059 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2851 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977036 [patent_doc_number] => 09023343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Phosphorylation-inhibiting agent or dephosphorylating agent for PTEN' [patent_app_type] => utility [patent_app_number] => 13/263876 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15519 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351308 [patent_doc_number] => 20100331265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/727647 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18300 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331265.pdf [firstpage_image] =>[orig_patent_app_number] => 12727647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807981 [patent_doc_number] => 20120058935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREFORE' [patent_app_type] => utility [patent_app_number] => 13/256171 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18453 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058935.pdf [firstpage_image] =>[orig_patent_app_number] => 13256171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042259 [patent_doc_number] => 20120070856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'CROSS-LINKING AGENTS' [patent_app_type] => utility [patent_app_number] => 13/254500 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12759 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070856.pdf [firstpage_image] =>[orig_patent_app_number] => 13254500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025766 [patent_doc_number] => 20110053837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Mineral-peptide chelates' [patent_app_type] => utility [patent_app_number] => 12/659241 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2436 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053837.pdf [firstpage_image] =>[orig_patent_app_number] => 12659241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239175 [patent_doc_number] => 08603966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Amino acid-based compounds, their methods of use, and methods of screening' [patent_app_type] => utility [patent_app_number] => 13/203490 [patent_app_country] => US [patent_app_date] => 2010-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10485 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042329 [patent_doc_number] => 20120070897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Method For Enucleating Nucleated Erythrocyte, And Enucleation Inducer' [patent_app_type] => utility [patent_app_number] => 13/202852 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11294 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070897.pdf [firstpage_image] =>[orig_patent_app_number] => 13202852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807236 [patent_doc_number] => 20120058190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'FOOD CONTAINING PROLACTIN' [patent_app_type] => utility [patent_app_number] => 13/201941 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9927 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058190.pdf [firstpage_image] =>[orig_patent_app_number] => 13201941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313595 [patent_doc_number] => 20120190625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'NOVEL PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/389051 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5725 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389051 [rel_patent_id] =>[rel_patent_doc_number] =>)